Cytogen, Inc. (KOSDAQ:217330)
5,710.00
+130.00 (2.33%)
At close: Apr 28, 2026
31.72% (1Y)
| Market Cap | 131.73B |
| Revenue (ttm) | 26.05B |
| Net Income (ttm) | -12.34B |
| Shares Out | 23.07M |
| EPS (ttm) | -535.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 569,446 |
| Average Volume | 381,618 |
| Open | 5,600.00 |
| Previous Close | 5,580.00 |
| Day's Range | 5,450.00 - 5,830.00 |
| 52-Week Range | 2,260.00 - 11,200.00 |
| Beta | -0.03 |
| RSI | 65.49 |
| Earnings Date | May 15, 2026 |